Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07750990
PHASE2

An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)

Sponsor: Shionogi

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to evaluate the long-term safety and tolerability profile of S-606001 in participants with LOPD. Participants who completed other S-606001 studies (for example, NCT07123155), including participants in a S-606001 study whose allocated arm was terminated by the sponsor and who are willing to participate in this study, will be enrolled globally.

Official title: A Phase 2, Open-label, Multicenter, Extension Study to Investigate the Long-term Safety and Efficacy of S-606001 in Patients With Late-onset Pompe Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-08-31

Completion Date

2028-08-31

Last Updated

2026-08-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

S-606001

S-606001 will be administered orally.

DRUG

ERT

ERT will be administered as an intravenous infusion.